Growth inhibition effect of HMME-mediated PDT on hepatocellular carcinoma HepG2 cells
Tóm tắt
Photodynamic therapy (PDT) is considered a promising new strategy for liver cancer treatment. Three elements of PDT—optical output power, irradiation time, and photosensitizer concentration—play important roles in promoting cell death. This research aimed to characterize the effects of hematoporphyrin monomethyl ether (HMME)-based PDT on hepatocellular carcinoma cells HepG2 and thus elucidate the relationship between cell death and the three elements mentioned earlier. Furthermore, in this study, we present a parameter that represents the cumulative effects of these elements. The accumulation of HMME in HepG2 cells was observed by fluorescence microscopy. The absorption spectrum of HMME was detected using fluorescence spectral analysis. The viability of the treated cells was determined using the MTT assay, and cell apoptosis was evaluated using flow cytometry. We found that the fluorescence intensity was positively correlated with the incubation time for up to 2 h. The cell growth inhibition rate was significantly high and gradually increased with increasing concentrations of HMME or increasing light intensity, which was calculated as optical output power × irradiation time. Further analysis revealed an e-exponential decay of the cell survival rate to the product of the HMME concentration and the light intensity. We defined the product as parameter B (B = optical output power × irradiation time × HMME concentration). Similarly, the rate of cell apoptosis showed roughly e-exponential growth to parameter B. In conclusion, HMME-mediated PDT can significantly kill HepG2 cells, and the killing effect was related to the cumulative effects of the optical output power, the irradiation time, and the HMME concentration. Therefore, the newly defined parameter B, as a comprehensive physical quantity, may be of great significance for the regulation of light and photosensitizer according to patient-specific conditions in clinical practice.
Tài liệu tham khảo
Sternberg ED, Dolphin D, Brückner C (1998) Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 54(17):4151–4202
Ben-Hurt E, Dubbelman TM (1993) Cytoplasmic free calcium changes as a trigger mechanism in the response of cells to photosensitization. Photochem Photobiol 58(6):890–894
Dougherty TJ (1992) Photochemistry in the treatment of cancer. Adv Photochem 17:275–311
Ringel I, Gottfried V, Levdansky L, Winkelman JW, Kimel S (1996) Photodynamic activity of porphines on tubulin assembly. Proc SPIE Photochemotherapy: Photodynamic Therapy and Other Modalities. 2625
Fingar VH, Potter WR, Henderson BW (1987) Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes. Photochem Photobiol 45(5):643–650
Hayata Y, Kato H, Konaka C, Ono J, Takizawa N (1982) Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. CHEST J 81(3):269–277
Krasner N, Chatlani P, Barr H (1990) Photodynamic therapy of tumours in gastroenterology—a review. Lasers Med Sci 5(2):233–239
Benson R Jr (1988) Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology 31(2 Suppl):13–17
Li J-H, Guo Z-H, Jin M-L et al (1990) Photodynamic therapy in the treatment of malignant tumours: an analysis of 540 cases. J Photochem Photobiol B Biol 6(1):149–155
Fukuchi K, Namiki Y, Okumura A, Morita S, Takahashi H, Ohura K (2004) Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells. Liver Int 24(2):142–148
Yow C, Wong C, Huang Z, Ho R (2007) Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell. Liver Int 27(2):201–208
Cortese D, Kinsey J (1984) Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. CHEST J 86(1):8–13
Kelley EE, Domann FE, Buettner GR, Oberley LW, Burns CP (1997) Increased efficacy of in vitro Photofrin® photosensitization of human oral squamous cell carcinoma by iron and ascorbate. J Photochem Photobiol B Biol 40(3):273–277
Byun JY, Choi HY, Myung KB, Choi YW (2009) Expression of IL-10, TGF-β1 and TNF-α in cultured keratinocytes (HaCaT cells) after IPL treatment or ALA-IPL photodynamic treatment. Ann Dermatol 21(1):12–17
Li YS, Zaidi S, Rodgers MA et al (1997) The synthesis, photophysical and photobiological properties and in vitro structure–activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol 65(3):581–586
Cai H, Gu Y, Sun Q, Zeng J, Dong N, Zhao G (2011) Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts. Photodermat, Photoimmunol Photomed 27(2):90–96
Sun Y, Xing D, Shen L et al (2013) Bactericidal effects of hematoporphyrin monomethyl ether-mediated photosensitization against pathogenic communities from supragingival plaque. Appl Microbiol Biotechnol 97(11):5079–5087
Wang J, Liu L, Pan S, Wang C, Fu Q (2009) Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. Neoplasma 57(1):79–85
Gao K, Huang Z, Yuan KH, Zhang B, Hu ZQ (2013) Side–by–side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks. Br J Dermatol 168(5):1040–1046
He Y, Ge H, Li S (2012) Haematoporphyrin based photodynamic therapy combined with hyperthermia provided effective therapeutic vaccine effect against colon cancer growth in mice. Int J Med Sci 9(8):627
Song K, Kong B, Qu X, Li L, Yang Q (2005) Phototoxicity of hemoporfin to ovarian cancer. Biochem Biophys Res Commun 337(1):127–132
Ding X, Xu Q, Liu F et al (2004) Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett 216(1):43–54
Gu Y, Huang N, Liang J, Pan Y, Liu F (2007) Clinical study of 1949 cases of port wine stains treated with vascular photodynamic therapy (Gu’s PDT)]. Annales de dermatologie et de vénéréologie 134:241
Yuan K-H, Li Q, Yu W-L, Zeng D, Zhang C, Huang Z (2008) Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: a retrospective analysis. Photodiagn Photodyn Ther 5(1):50–57
Li C, Cheng L, Wang Z, Gu Y (2009) Attempt of photodynamic therapy on esophageal varices. Lasers Med Sci 24(2):167–171
Zhan Q, Yue W, Hu S (2011) Effect of photodynamic therapy and endostatin on human glioma xenografts in nude mice. Photodiagn Photodyn Ther 8(4):314–320
Yin H, Li Y, Zheng Y et al (2012) Photoinactivation of cell-free human immunodeficiency virus by hematoporphyrin monomethyl ether. Lasers Med Sci 27(5):943–950
Cheng J, Liang H, Li Q et al (2010) Hematoporphyrin monomethyl ether-mediated photodynamic effects on THP-1 cell-derived macrophages. J Photochem Photobiol B Biol 101(1):9–15
Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist 15(4):5–13
Pizova K, Tomankova K, Daskova A, Binder S, Bajgar R, Kolarova H (2012) Photodynamic therapy for enhancing antitumour immunity. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156(2):93–102
Sherifa G, Zaghloul S, Elsayed O, et al. (2012) Functional characterization of Fospeg, and its impact on cell cycle upon PDT of Huh7 hepatocellular carcinoma cell model. Photodiagnosis and Photodynamic Therapy
Wang C-Y, Wang X, Wang Y, et al. (2012) Photosensitization of phycocyanin extracted from Microcystis in human hepatocellular carcinoma cells: implication of mitochondria-dependent apoptosis. J Photochem Photobiol B: Biol
Shao J, Xue J, Dai Y et al (2012) Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest. Eur J Cancer 48(13):2086–2096
Andrzejak M, Price M, Kessel DH (2011) Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells. Autophagy 7(9):979–984
Tang PM-K, Bui-Xuan N-H, Wong C-K, Fong W-P, Fung K-P (2010) Pheophorbide a-mediated photodynamic therapy triggers HLA class I-restricted antigen presentation in human hepatocellular carcinoma. Transl Oncol 3(2):114
A’Amar OM, Ley RD, Bigio IJ (2004) Comparison between ultraviolet–visible and near-infrared elastic scattering spectroscopy of chemically induced melanomas in an animal model. J Biomed Opt 9(6):1320–1326
Zeng C, Yang D, Huang P, et al. (1996) Ultrasound-guided interventional PDT of liver cancer. Photonics China’96; 1996: International Society for Optics and Photonics 68–72.
Song K, Kong B, Li L, Yang Q, Wei Y, Qu X (2007) Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether. Cancer Sci 98(12):1959–1964
Matroule J-Y, Carthy CM, Granville DJ, Jolois O, Hunt D, Piette J (2001) Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 20(30):4070
Barathan M, Mariappan V, Shankar E, Abdullah BJ, Goh K, Vadivelu J (2013) Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Cell Death Dis 4(6):e697